- Home
- WETH vs NERV Comparison
WETH vs NERV Comparison
Compare WETH & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WETH
- NERV
- Stock Information
- Founded
- WETH 1992
- NERV 2007
- Country
- WETH China
- NERV United States
- Employees
- WETH N/A
- NERV N/A
- Industry
- WETH
- NERV Biotechnology: Pharmaceutical Preparations
- Sector
- WETH
- NERV Health Care
- Exchange
- WETH Nasdaq
- NERV Nasdaq
- Market Cap
- WETH 10.9M
- NERV 12.0M
- IPO Year
- WETH N/A
- NERV 2014
- Fundamental
- Price
- WETH $1.23
- NERV $2.27
- Analyst Decision
- WETH
- NERV Hold
- Analyst Count
- WETH 0
- NERV 1
- Target Price
- WETH N/A
- NERV $5.00
- AVG Volume (30 Days)
- WETH 199.2K
- NERV 41.1K
- Earning Date
- WETH 09-12-2025
- NERV 08-14-2025
- Dividend Yield
- WETH N/A
- NERV N/A
- EPS Growth
- WETH N/A
- NERV N/A
- EPS
- WETH 0.34
- NERV 1.48
- Revenue
- WETH $41,024,264.00
- NERV N/A
- Revenue This Year
- WETH N/A
- NERV N/A
- Revenue Next Year
- WETH N/A
- NERV N/A
- P/E Ratio
- WETH $3.32
- NERV $1.59
- Revenue Growth
- WETH 2.86
- NERV N/A
- 52 Week Low
- WETH $0.76
- NERV $1.15
- 52 Week High
- WETH $2.96
- NERV $3.00
- Technical
- Relative Strength Index (RSI)
- WETH 69.41
- NERV 57.24
- Support Level
- WETH $0.82
- NERV $2.31
- Resistance Level
- WETH $1.19
- NERV $2.47
- Average True Range (ATR)
- WETH 0.09
- NERV 0.17
- MACD
- WETH 0.03
- NERV 0.01
- Stochastic Oscillator
- WETH 87.18
- NERV 60.12
About WETH Wetouch Technology Inc.
Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.